These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The BtaF Adhesin Is Necessary for Full Virulence During Respiratory Infection by Muñoz González F; Sycz G; Alonso Paiva IM; Linke D; Zorreguieta A; Baldi PC; Ferrero MC Front Immunol; 2019; 10():1775. PubMed ID: 31402921 [No Abstract] [Full Text] [Related]
7. Establishment of Chronic Infection: Brucella's Stealth Strategy. Ahmed W; Zheng K; Liu ZF Front Cell Infect Microbiol; 2016; 6():30. PubMed ID: 27014640 [TBL] [Abstract][Full Text] [Related]
8. Virulence factors in brucellosis: implications for aetiopathogenesis and treatment. Fugier E; Pappas G; Gorvel JP Expert Rev Mol Med; 2007 Dec; 9(35):1-10. PubMed ID: 18088444 [TBL] [Abstract][Full Text] [Related]
9. The innate immune response against Brucella in humans. Dornand J; Gross A; Lafont V; Liautard J; Oliaro J; Liautard JP Vet Microbiol; 2002 Dec; 90(1-4):383-94. PubMed ID: 12414158 [TBL] [Abstract][Full Text] [Related]
10. [Evasion of anti-infectious immunity by Brucella - A review]. Quan W; Yang Y Wei Sheng Wu Xue Bao; 2016 May; 56(5):747-52. PubMed ID: 29727136 [TBL] [Abstract][Full Text] [Related]
11. Immunogenic and protective antigens of Brucella as vaccine candidates. Masjedian Jezi F; Razavi S; Mirnejad R; Zamani K Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():29-36. PubMed ID: 31300122 [TBL] [Abstract][Full Text] [Related]
12. Innate immune encounters of the (Type) 4th kind: Brucella. de Jong MF; Rolán HG; Tsolis RM Cell Microbiol; 2010 Sep; 12(9):1195-202. PubMed ID: 20670294 [TBL] [Abstract][Full Text] [Related]
14. Brucella virulence mechanisms and implications in novel vaccines and drugs. Gao G; Wang Y; Chen Z; Xu X; Xu J Crit Rev Eukaryot Gene Expr; 2013; 23(1):49-64. PubMed ID: 23557337 [TBL] [Abstract][Full Text] [Related]
15. Antigen-specific acquired immunity in human brucellosis: implications for diagnosis, prognosis, and vaccine development. Cannella AP; Tsolis RM; Liang L; Felgner PL; Saito M; Sette A; Gotuzzo E; Vinetz JM Front Cell Infect Microbiol; 2012; 2():1. PubMed ID: 22919593 [TBL] [Abstract][Full Text] [Related]
16. A review of the immunopathogenesis of Brucellosis. Amjadi O; Rafiei A; Mardani M; Zafari P; Zarifian A Infect Dis (Lond); 2019 May; 51(5):321-333. PubMed ID: 30773082 [TBL] [Abstract][Full Text] [Related]
17. Dendritic cells and Brucella spp. interaction: the sentinel host and the stealthy pathogen. Avila-Calderón ED; Flores-Romo L; Sharon W; Donis-Maturano L; Becerril-García MA; Arreola MGA; Reynoso BA; Güemes FS; Contreras-Rodríguez A Folia Microbiol (Praha); 2020 Feb; 65(1):1-16. PubMed ID: 30783994 [TBL] [Abstract][Full Text] [Related]
18. Research progress in live attenuated Brucella vaccine development. Wang Z; Wu Q Curr Pharm Biotechnol; 2013; 14(10):887-96. PubMed ID: 24372253 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis. Al-Mariri A; Abbady AQ J Infect Dev Ctries; 2013 Apr; 7(4):329-37. PubMed ID: 23592643 [TBL] [Abstract][Full Text] [Related]